5 Key Takeaways from Health Insurers’ New Pledge to Improve Prior Authorization
In a significant development, the largest U.S. health insurers have agreed to streamline the often frustrating and cumbersome prior authorization process that affects millions of patients’ access to medical care. This agreement comes nearly seven months after the tragic killing of UnitedHealthcare CEO Brian Thompson in New York, which drew national attention to the systemic delays and denials of doctor-approved treatments caused by prior authorization requirements.
Health and Human Services Secretary Robert F. Kennedy Jr. and Dr. Mehmet Oz, administrator of the Centers for Medicare & Medicaid Services (CMS), announced the industry’s commitments on June 24, 2025. Dozens of major insurance companies, including Cigna, Aetna, Humana, and UnitedHealthcare, pledged a series of reforms aimed at reducing patient wait times and improving transparency in the prior authorization process.
While officials from the Trump administration praised the insurers for their willingness to address this long-standing issue, they emphasized that the initiative remains voluntary and has its limits. Below are five essential takeaways consumers should know about this new pledge.
1. Prior Authorization Isn’t Going Away
Despite the insurers’ promises to reduce burdensome requirements, prior authorization will remain in place, allowing insurers to deny doctor-recommended care. This remains the most significant criticism from patients and providers alike, as the process can delay or even prevent timely access to necessary treatments, especially for seriously ill patients who need expensive, specialized care such as cancer treatments.
The reforms do not guarantee protection for the sickest patients, and much of the prior authorization system’s impact continues to operate behind a “black box,” where patients often do not even realize their care is subject to these reviews until a denial occurs.
2. Reform Efforts Are Not New
Many states have already enacted laws aimed at reducing the time patients spend waiting for prior authorization decisions and increasing insurance companies’ transparency. Some have implemented “gold card” programs that exempt doctors with strong prior authorization approval records from these requirements altogether.
Furthermore, federal regulations that began in the Trump administration and were finalized under Biden will take effect next year. These rules mandate insurers to respond electronically within seven days (or 72 hours in urgent cases), improving efficiency but only applying to Medicare Advantage and Medicaid plans.
Several insurers, such as UnitedHealthcare and Cigna, had already begun making improvements this year, including reducing prior authorization volume and streamlining processes before this new pledge was announced.
3. Insurers Should Already Be Doing Some of These Things
The Affordable Care Act requires health insurers to communicate plan benefits and coverage details in plain language, yet many denial letters remain complex and filled with industry jargon. For example, the industry trade group AHIP’s use of terms like “non-approved requests” reflects ongoing communication challenges.
Insurers promised medical professionals would continue to review denials, a practice AHIP says is standard. However, recent lawsuits claim that some denials happen within seconds without meaningful clinical assessment, which contradicts these assurances.
4. Increased Use of Artificial Intelligence (AI) in Prior Authorization Decisions
Health insurers currently deny millions of requests annually, although most prior authorizations are approved quickly. The industry plans to leverage AI further, aiming to process 80% of prior authorization decisions in real-time by 2027. While AI holds promise to make prior authorization faster and more efficient, there are concerns about its accuracy and fairness. For instance, a recent American Medical Association survey found that 61% of physicians worry AI use by insurers is already leading to more denials. Experts stress that AI’s effectiveness depends heavily on the quality of data and algorithms used.
5. Many Details Remain Unclear
CMS administrator Dr. Oz said that a full list of participating insurers would be published this summer, with additional details—including performance targets and public data dashboards—expected by January 2026. However, specifics on how insurers will be held accountable or the exact medical services exempted from prior authorization have yet to be disclosed.
Patient and physician advocates welcome the announcement but urge greater transparency and follow-through. They point out that insurers have made similar pledges in the past, such as in 2018, that failed to deliver significant change.
Efforts are underway to identify “low-value” procedures that should no longer require prior authorization, but the timeline for releasing this information and insurer compliance is still uncertain.
Conclusion
The new prior authorization pledge by major U.S. health insurers represents a hopeful step toward reducing administrative barriers in healthcare and improving patient access to timely treatment. However, experts caution that prior authorization will remain part of the insurance landscape, and meaningful improvements depend on transparent enforcement and clear, sustained commitments.
As this initiative unfolds over the coming months, patients, providers, and policymakers will watch closely to see if insurers’ promises translate into faster, fairer, and more understandable access to care.
This article is brought to you by Smart Money Mindset, your trusted source for timely health and financial news.